OTTAWA, Jan. 25 /CNW/ - Nordion Inc., a leading provider of products and
services to the global health science market, today announced it has
signed a five-year contract with Sterigenics International, a global
leader in contract sterilization and ionization services, for the
supply of Cobalt-60. Under the terms of the agreement, this contract
extends until October 31, 2015.
"This contract provides for growth, further demonstrates the
attractiveness of this core business, and builds on our global market
leadership position," said Steve West, Chief Executive Officer,
Nordion. "We continue to drive value for our sterilization customers
and the industries they serve through a high quality and reliable
supply of isotopes and world-class engineering and logistics
For more than 40 years, Cobalt-60 has been a critical component of gamma
technology, providing reliable and highly effective sterilization.
Gamma sterilization is used for more than 40 per cent of the world's
single-use medical supplies and devices each year including bandages,
catheters and syringes. This technology is also used for bio-burden
reduction in a variety of consumer products including spices, food
packaging and cosmetics.
"Nordion and Sterigenics have a successful and long standing history of
working together," said Dave Meyer, Chief Executive Officer,
Sterigenics. "With Nordion's multi-source capabilities and their solid
expertise in manufacturing, engineering, transportation and
distribution, we can continue to offer our customers the reliability in
service they have come to appreciate and expect."
About Nordion Inc.
Nordion Inc. (TSX: NDN; NYSE: NDZ) is a global specialty health science
company that provides market-leading products used for the prevention,
diagnosis and treatment of disease. We are a leading provider of
medical isotopes, targeted therapies and sterilization technologies
that benefit the lives of millions of people in more than 60 countries
around the world. Our products are used daily by pharmaceutical and
biotechnology companies, medical-device manufacturers, hospitals,
clinics and research laboratories. Nordion has more than 600 highly
skilled employees in four locations. Find out more at www.nordion.com.
Forward Looking Statements
Certain statements contained in this news release constitute
"forward-looking statements". These statements are based on current
beliefs and assumptions of management, however are subject to known and
unknown risks, uncertainties and other factors that may cause actual
results to differ materially from the forward-looking statements in
this news release. For additional information with respect to certain
of these beliefs, assumptions, risks and uncertainties, please refer to
Nordion's Annual Information Form for fiscal 2010 available on SEDAR at
www.sedar.com and on EDGAR on www.sec.gov.
SOURCE Nordion Inc.
For further information:
(613) 592-3400 x. 2414